Minimum 10-year postoperative health related quality of life and hip function in patients with total hip arthroplasty
2007 Mariconda, M; Lotti, G; Galasso, O; Cozzolino, A; Secondulfo, V; Iannò, B; Della Rotonda, G; Cozzolino, F; Milano, C
Outcome predictors of carpal tunnel syndrome surgery
2011 Galasso, O; Mariconda, M; Iannò, B; Cundari, A; De Nardo, P; Gasparini, G
Extracorporeal shock wave therapy for avascular osteonecrosis of the femoral head
2001 Galasso, O; Corrado, B; Gigliotti, S; Russo, S
The properties of coloured bone cement
2013 Guzzi, P; Pugliese, T; Galasso, O; Gasparini, G
Crispr/Cas9-Induced DNMT3A Mutations in the K562 Human Leukemic Cell Line As a Model of DNMT3A-Mutated Leukemogenesis
2016 Banaszak, Lg; Giudice, V; Zhao, X; Wu, Zj; Hosokawa, K; Keyvanfar, K; Townsley, D; Kajigaya, S; Young, Ns
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors
2016 Savastano, B; Della Corte, Cm; Papaccio, F; Giuseppe, V; Esposito, G; Fasano, M; Orditura, M; De Vita, F; Ciardiello, F; Morgillo, F
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites
2018 Morgillo, F; Della Corte, Cm; Viscardi, G; Di Liello, R; Papaccio, F; Ciardiello, F
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition
2019 Valiente, Fg; Tarazona, N; Gambardella, V; Riffo-Campos, A; Papaccio, F; Cabeza-Segura, M; López-Rodas, G; Cervantes, A; Franco, L; Castillo, J
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence
2016 Esposito, G; Della Corte, Cm; Papaccio, F; Viscardi, G; Fasano, M; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness
2017 Viscardi, G; Ciaramella, V; Della Corte, Cm; Papaccio, F; Esposito, G; Di Liello, R; Troiani, T; Orditura, M; Ciardiello, F; Morgillo, F
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor
2020 Papaccio, F; Bravo, Mfg; Cabeza-Segura, M; Gimeno-Valiente, F; Gambardella, V; Garzón-Lloría, Z; García-Micó, B; Huerta, M; Martínez-Ciarpaglini, C; Alfaro-Cervello, C; Sabater, L; Lombardi, P; Rentero-Garrido, P; Zúñiga-Trejos, S; Keränen, Sr; Fleitas, T; Tarazona, N; Roda, D; Cervantes, A; Castillo, J
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy
2017 Barra, G; Pasquale, G; Della Corte, C; Papaccio, F; Ciardiello, F; Morgillo, F; De Palma, R
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC
2019 Viscardi, G; Sparano, F; Di Liello, R; Casal, Ga; Ferreres, Rb; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, Ml; Della Corte, Cm; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, Pm; Molla, Mai
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations
2016 Viscardi, G; Della Corte, Cm; Papaccio, F; Esposito, G; Fasano, M; Martinelli, E; Troiani, T; Ciardiello, F; Morgillo, F
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models
2020 Gambardella, V; Gimeno-Valiente, F; Cabeza, M; Papaccio, F; Zúñiga-Trejos, S; Carbonell-Asins, Ja; Rentero-Garrido, P; Huerta, M; Keränen, Sr; Cejalvo, Jm; Roda, D; Tarazona, N; Fleitas, T; Cervantes, A; Castillo, J
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients
2020 Cabeza, M; Papaccio, F; Bravo, Mfg; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance
2016 Papaccio, F; Della Corte, Cm; Viscardi, G; Esposito, G; Fasano, M; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC)
2017 Bruixola, G; Caballero, J; Papaccio, F; Petrillo, A; Pastor, M; Cervantes, A
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites
2017 Della Corte, Cm; Barra, G; Ciaramella, V; Papaccio, F; Viscardi, G; Esposito, G; Di Liello, R; Orditura, M; Troiani, T; De Palma, R; Ciardiello, F; Morgillo, F
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial
2016 Fasano, M; Della Corte, Cm; Papaccio, F; Viscardi, G; Esposito, G; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Minimum 10-year postoperative health related quality of life and hip function in patients with total hip arthroplasty | 1-gen-2007 | Mariconda, M; Lotti, G; Galasso, O; Cozzolino, A; Secondulfo, V; Iannò, B; Della Rotonda, G; Cozzolino, F; Milano, C | |
| Outcome predictors of carpal tunnel syndrome surgery | 1-gen-2011 | Galasso, O; Mariconda, M; Iannò, B; Cundari, A; De Nardo, P; Gasparini, G | |
| Extracorporeal shock wave therapy for avascular osteonecrosis of the femoral head | 1-gen-2001 | Galasso, O; Corrado, B; Gigliotti, S; Russo, S | |
| The properties of coloured bone cement | 1-gen-2013 | Guzzi, P; Pugliese, T; Galasso, O; Gasparini, G | |
| Crispr/Cas9-Induced DNMT3A Mutations in the K562 Human Leukemic Cell Line As a Model of DNMT3A-Mutated Leukemogenesis | 1-gen-2016 | Banaszak, Lg; Giudice, V; Zhao, X; Wu, Zj; Hosokawa, K; Keyvanfar, K; Townsley, D; Kajigaya, S; Young, Ns | |
| Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors | 1-gen-2016 | Savastano, B; Della Corte, Cm; Papaccio, F; Giuseppe, V; Esposito, G; Fasano, M; Orditura, M; De Vita, F; Ciardiello, F; Morgillo, F | |
| Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites | 1-gen-2018 | Morgillo, F; Della Corte, Cm; Viscardi, G; Di Liello, R; Papaccio, F; Ciardiello, F | |
| ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition | 1-gen-2019 | Valiente, Fg; Tarazona, N; Gambardella, V; Riffo-Campos, A; Papaccio, F; Cabeza-Segura, M; López-Rodas, G; Cervantes, A; Franco, L; Castillo, J | |
| Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence | 1-gen-2016 | Esposito, G; Della Corte, Cm; Papaccio, F; Viscardi, G; Fasano, M; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F | |
| Met/Axl system as a dual target in the mesothelioma pathway and invasiveness | 1-gen-2017 | Viscardi, G; Ciaramella, V; Della Corte, Cm; Papaccio, F; Esposito, G; Di Liello, R; Troiani, T; Orditura, M; Ciardiello, F; Morgillo, F | |
| Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor | 1-gen-2020 | Papaccio, F; Bravo, Mfg; Cabeza-Segura, M; Gimeno-Valiente, F; Gambardella, V; Garzón-Lloría, Z; García-Micó, B; Huerta, M; Martínez-Ciarpaglini, C; Alfaro-Cervello, C; Sabater, L; Lombardi, P; Rentero-Garrido, P; Zúñiga-Trejos, S; Keränen, Sr; Fleitas, T; Tarazona, N; Roda, D; Cervantes, A; Castillo, J | |
| Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy | 1-gen-2017 | Barra, G; Pasquale, G; Della Corte, C; Papaccio, F; Ciardiello, F; Morgillo, F; De Palma, R | |
| A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC | 1-gen-2019 | Viscardi, G; Sparano, F; Di Liello, R; Casal, Ga; Ferreres, Rb; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, Ml; Della Corte, Cm; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, Pm; Molla, Mai | |
| Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations | 1-gen-2016 | Viscardi, G; Della Corte, Cm; Papaccio, F; Esposito, G; Fasano, M; Martinelli, E; Troiani, T; Ciardiello, F; Morgillo, F | |
| An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models | 1-gen-2020 | Gambardella, V; Gimeno-Valiente, F; Cabeza, M; Papaccio, F; Zúñiga-Trejos, S; Carbonell-Asins, Ja; Rentero-Garrido, P; Huerta, M; Keränen, Sr; Cejalvo, Jm; Roda, D; Tarazona, N; Fleitas, T; Cervantes, A; Castillo, J | |
| 3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients | 1-gen-2020 | Cabeza, M; Papaccio, F; Bravo, Mfg; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J | |
| Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance | 1-gen-2016 | Papaccio, F; Della Corte, Cm; Viscardi, G; Esposito, G; Fasano, M; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F | |
| Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) | 1-gen-2017 | Bruixola, G; Caballero, J; Papaccio, F; Petrillo, A; Pastor, M; Cervantes, A | |
| Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites | 1-gen-2017 | Della Corte, Cm; Barra, G; Ciaramella, V; Papaccio, F; Viscardi, G; Esposito, G; Di Liello, R; Orditura, M; Troiani, T; De Palma, R; Ciardiello, F; Morgillo, F | |
| Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial | 1-gen-2016 | Fasano, M; Della Corte, Cm; Papaccio, F; Viscardi, G; Esposito, G; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1217
Data di pubblicazione
- 2020 - 2026127
- 2010 - 2019458
- 2000 - 2009357
- 1990 - 1999217
- 1980 - 198957
- 1978 - 19791
Editore
- wiley blackwell1
Rivista
- DIGESTIVE AND LIVER DISEASE53
- HAEMATOLOGICA53
- JOURNAL OF ALLERGY AND CLINICAL I...45
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...44
- BLOOD42
- JOURNAL OF PEDIATRIC GASTROENTERO...37
- RIVISTA DI STUDI POLITICI INTERNA...28
- ANNALS OF ONCOLOGY27
- BONE MARROW TRANSPLANTATION25
- CIRCULATION23
Keyword
- pediatrics109
- Novità12
- Humans3
- Ring closure reactions3
- rinvenimenti monetali3
- Animals2
- autologous bone graft2
- Cardiovascular Diseases2
- Covid-192
- Green extraction technologies2
Lingua
- eng898
- ita100
- fre2
- cze1
Accesso al fulltext
- no fulltext1216
- open1